Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria
- PMID: 32985028
- DOI: 10.1111/tmi.13497
Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria
Abstract
Objective(s): To determine the availability and affordability of asthma and COPD medicines across Nigeria.
Methods: This was a cross-sectional survey conducted in 128 pharmacies (51 in public sector hospitals, 51 private sector community pharmacies and 26 charity or big private hospitals) across the six geopolitical zones of Nigeria using the WHO/Health Action Initiative method. The proportion of pharmacies where medicines were available, the median retail prices of originator and generics and affordability were analysed. A medicine was available if found in ≥ 80% of surveyed pharmacies. Unaffordability was defined as paying> 1 day's wage (> US$1.68) for a standard 30-day supply of the medicine.
Results: The available medicines were oral corticosteroids and oral salbutamol which are not on the WHO Essential Medicine List. Medicines were found more frequently in private than public pharmacies and in the southern than northern zones. Inhalable corticosteroid was not available at any public pharmacy nationwide. None of the EML medicines were affordable. The least number of days' wages for a 30-day supply of any inhalable corticosteroid-containing medication was 3.5 days.
Conclusions: There are very limited availability and affordability of recommended asthma and COPD medicines across Nigeria with disparity across regions. Medicines that were available and affordable are not recommended and are harmful for long-term use. This underpins the need for engagement of all stakeholders for the review of existing policies regarding access to asthma and COPD medicines to improve availability and affordability.
Keywords: Nigeria; affordability; asthma; availability; chronic obstructive pulmonary disease; medicine.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.Lancet Glob Health. 2022 Oct;10(10):e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8. Lancet Glob Health. 2022. PMID: 36113528 Free PMC article.
-
Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.PLoS One. 2019 Apr 25;14(4):e0216122. doi: 10.1371/journal.pone.0216122. eCollection 2019. PLoS One. 2019. PMID: 31022276 Free PMC article.
-
Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.PLoS One. 2017 Feb 7;12(2):e0171284. doi: 10.1371/journal.pone.0171284. eCollection 2017. PLoS One. 2017. PMID: 28170413 Free PMC article.
-
Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.BMJ Open. 2018 Oct 18;8(10):e023646. doi: 10.1136/bmjopen-2018-023646. BMJ Open. 2018. PMID: 30341137 Free PMC article.
-
High medicine prices and poor affordability.Curr Opin Psychiatry. 2011 Jul;24(4):341-5. doi: 10.1097/YCO.0b013e3283477b68. Curr Opin Psychiatry. 2011. PMID: 21532479 Review.
Cited by
-
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.Lancet Glob Health. 2022 Oct;10(10):e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8. Lancet Glob Health. 2022. PMID: 36113528 Free PMC article.
-
Catastrophic health expenditure, social protection coverage, and financial coping strategies in adults with symptoms of chronic respiratory diseases in Kenya: a cross-sectional study.Lancet Glob Health. 2025 Jul;13(7):e1301-e1313. doi: 10.1016/S2214-109X(25)00061-0. Lancet Glob Health. 2025. PMID: 40580995 Free PMC article.
-
Decreased prevalence and severity of asthma symptoms among adolescents in Ibadan, Nigeria, 1995-2018.Int J Tuberc Lung Dis. 2023 Dec 1;27(12):925-930. doi: 10.5588/ijtld.23.0138. Int J Tuberc Lung Dis. 2023. PMID: 38042979 Free PMC article.
-
Health-related quality of life in asthma measured by the World Health Organization brief questionnaire (WHO-BREF) and the effect of concomitant allergic rhinitis-A population-based study.Clin Respir J. 2025 Mar;19(3):e13608. doi: 10.1111/crj.13608. Epub 2023 Apr 4. Clin Respir J. 2025. PMID: 37016072 Free PMC article.
-
Meeting Unmet Needs in Chronic Obstructive Pulmonary Disease Diagnosis and Treatment in Low- and Middle-Income Countries.Am J Respir Crit Care Med. 2023 Aug 15;208(4):352-354. doi: 10.1164/rccm.202307-1167ED. Am J Respir Crit Care Med. 2023. PMID: 37459643 Free PMC article. No abstract available.
References
-
- World Health Organization. Progress towards the SDGs : A selection of data from World Health. Statistics 2018: 2015: 4-7.
-
- World Health Organization. Global action plan for the prevention and control of noncommunicable diseases. 2013-2020. 2013. (Available from: http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf). [4 Feb 2020].
-
- WHOMonitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. WHO. (Available from: https://www.who.int/healthinfo/systems/monitoring/en/) [5 Feb 2020].
-
- World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Heal Organ Internet 2013102 (Available from: https://www.appswhointirisBitstream106659438419789241506236engpdf2013).
-
- Wang H, Naghavi M, Allen C et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016: 388: 1459-544.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical